Matthew Moyle
52Patents
11h-index
35Co-inventors
78Inventor score
Filing activity: May 11, 1993 → Jun 5, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7674459B2 | Treatment of cancer with a novel anti-IL13 monoclonal antibody | Chemistry; Metallurgy | 35 | Expired |
| US6090916A | Nematode-extracted serine protease inhibitors and anticoagulant proteins | Emerging Cross-Sectional Technologies | 32 | Expired |
| US8088618B2 | Anti-IL 13 antibodies and uses thereof | Chemistry; Metallurgy | 26 | Active |
| US8067199B2 | Anti-IL13 antibodies and uses thereof | Chemistry; Metallurgy | 23 | Active |
| US8318160B2 | Treatment of cancer with novel anti-IL13 monoclonal antibodies | Chemistry; Metallurgy | 20 | Active |
| US9464131B2 | Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody | Chemistry; Metallurgy | 14 | Active |
| US9051362B2 | Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity | Chemistry; Metallurgy | 14 | Active |
| US10087239B2 | Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody | Chemistry; Metallurgy | 12 | Active |
| US9605065B2 | Anti-IL13 antibodies and uses thereof | Chemistry; Metallurgy | 12 | Active |
| US5919900A | Modified hookworm neutrophil inhibitors | Mechanical Engineering; Lighting; Heating | 11 | Expired |
| US5866542A | Nematode-extracted anticoagulant protein | Human Necessities | 11 | Expired |
| US6040441A | Nematode-extracted serine protease inhibitors and anticoagulant proteins | Emerging Cross-Sectional Technologies | 8 | Expired |
| US5635601A | Beta-8 integrin subunit antibodies | Chemistry; Metallurgy | 8 | Expired |
| US8916160B2 | Compositions and methods for the therapy and diagnosis of influenza | Physics | 8 | Active |
| US6872808B1 | Nematode-extracted serine protease inhibitors and anticoagulant proteins | Emerging Cross-Sectional Technologies | 7 | Expired |
| US8057796B2 | Compositions and methods for the therapy and diagnosis of influenza | Chemistry; Metallurgy | 6 | Active |
| US5708141A | Neutrophil inhibitors | Human Necessities | 5 | Expired |
| US5866543A | Nematode-extracted anticoagulant protein | Human Necessities | 4 | Expired |
| US5863894A | Nematode-extracted anticoagulant protein | Human Necessities | 4 | Expired |
| US8114402B2 | Compositions and methods for the therapy and diagnosis of influenza | Chemistry; Metallurgy | 4 | Active |
| US5872098A | Nematode-extracted anticoagulant protein | Human Necessities | 4 | Expired |
| US6087487A | Nematode-extracted serine protease inhibitors and anticoagulant proteins | Emerging Cross-Sectional Technologies | 4 | Expired |
| US5789178A | Neutrophil inhibitors | Human Necessities | 3 | Expired |
| US5955294A | Nematode-extracted serine protease inhibitors and anticoagulant proteins | Chemistry; Metallurgy | 3 | Expired |
| US6096877A | Nematode-extracted serine protease inhibitors and anticoagulant proteins | Emerging Cross-Sectional Technologies | 2 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.